Indian Counterpart Asks U.S. HHS To Intervene In Ranbaxy Dispute
This article was originally published in PharmAsia News
Executive Summary
India's health ministry, acting on behalf of Ranbaxy Laboratories, is asking its U.S. counterpart to intervene in a dispute with U.S. FDA over allegations Ranbaxy imported adulterated drugs into the country. The head of India's Chemicals and Fertiliser Ministry made the appeal in a letter to Michael Leavitt, secretary of Health and Human Services. Ram Vilas Paswan asked Leavitt to "have the matter resolved at the earliest." Paswan agreed with Ranbaxy that it had not been involved in wrongdoing and that the firm has cooperated with U.S. authorities so it can get an amicable resolution of the dispute. (Click here for more